EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M503. A total of 13 filers reported holding EYEGATE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,000 | +50.0% | 1,468 | +213.7% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 468 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 468 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 468 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 468 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | -50.0% | 468 | -34.5% | 0.00% | – |
| Q1 2020 | $4,000 | – | 714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,792,500 | $8,438,000 | 0.56% |
| Golden State Wealth Management, LLC | 1,786 | $6,000 | 0.00% |
| US BANCORP \DE\ | 2,710 | $9,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 147 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 6 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 533 | $2,000 | 0.00% |
| BlackRock Inc. | 42 | $0 | 0.00% |
| MORGAN STANLEY | 342 | $1,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 1,100 | $4,000 | 0.00% |